CVS Health’s narrative has shifted with a slightly higher fair value estimate, nudging from about $91.50 to roughly $92.40 per share as analysts factor in modestly stronger long term revenue growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback